RDH12 and respiratory distress syndrome in premature infants: Although this requirement clearly poses a hurdle to early onset diseases, such as RDH12-associated IRDs, it was suggested there may be no need or requirement to prove efficacy in adults if non-clinical animal models can be used to provide such proof; or a single adult individual may be sufficient to provide a valid demonstration of efficacy for a novel drug/therapy.